Back
Amicus Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
45
FOLD
Amicus Therapeutics
Last Price:
10.71
Seasonality Move:
-8.45%
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-22.66%
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $10.71. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $10.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -426216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11 - 11.58) | Sell |
| Bollinger Bands (100): | (9.77 - 11.27) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 57.14 | Buy |
| Chaikin Money Flow: | 63291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.64) | Buy |
| Bollinger Bands (100): | (0.44 - 3.24) | Sell |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Sell |
| 20-day SMA: | 11.25 | Sell |
| 50-day SMA: | 11.05 | Sell |
| 200-day SMA: | 11.43 | Sell |
| 8-day EMA: | 10.96 | Sell |
| 20-day EMA: | 11.13 | Sell |
| 50-day EMA: | 11.04 | Sell |
| 200-day EMA: | 11.14 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Buy |
| 20-day SMA: | 0.55 | Buy |
| 50-day SMA: | 0.69 | Buy |
| 200-day SMA: | 3.51 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.61 | Buy |
| 50-day EMA: | 0.9 | Sell |
| 200-day EMA: | 7.9 | Sell |
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Amicus Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||